Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with (64)Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts

Peritoneal dissemination is a common cause of death from gastrointestinal cancers and is difficult to treat using current therapeutic options, particularly late-phase disease. Here, we investigated the feasibility of integrated therapy using (64)Cu-intraperitoneal radioimmunotherapy (ipRIT), alone o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshii, Yukie, Yoshimoto, Mitsuyoshi, Matsumoto, Hiroki, Tashima, Hideaki, Iwao, Yuma, Takuwa, Hiroyuki, Yoshida, Eiji, Wakizaka, Hidekatsu, Yamaya, Taiga, Zhang, Ming-Rong, Sugyo, Aya, Hanadate, Sayaka, Tsuji, Atsushi B., Higashi, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034757/
https://www.ncbi.nlm.nih.gov/pubmed/29989003
http://dx.doi.org/10.18632/oncotarget.25649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034757/
https://www.ncbi.nlm.nih.gov/pubmed/29989003
http://dx.doi.org/10.18632/oncotarget.25649

Ejemplares similares